+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Kidney Transplant"

North America Biopsy Procedures Count by Segments and Forecast to 2030 - Product Thumbnail Image

North America Biopsy Procedures Count by Segments and Forecast to 2030

  • Report
  • April 2023
  • 192 Pages
  • North America
From
EU5 Biopsy Procedures Count by Segments and Forecast to 2030 - Product Thumbnail Image

EU5 Biopsy Procedures Count by Segments and Forecast to 2030

  • Report
  • April 2023
  • 306 Pages
  • Europe
From
Asia-Pacific Biopsy Procedures Count by Segments and Forecast to 2030 - Product Thumbnail Image

Asia-Pacific Biopsy Procedures Count by Segments and Forecast to 2030

  • Report
  • April 2023
  • 306 Pages
  • Asia Pacific
From
BRIC Biopsy Procedures Count by Segments and Forecast to 2030 - Product Thumbnail Image

BRIC Biopsy Procedures Count by Segments and Forecast to 2030

  • Report
  • April 2023
  • 249 Pages
  • Russia, India, China, ... Russia, India, China, Brazil
From
Loading Indicator

The Kidney Transplant market is a subset of the biotechnology industry that focuses on the development of treatments and technologies related to kidney transplantation. This includes the development of new drugs, medical devices, and surgical techniques to improve the safety and efficacy of kidney transplantation. Additionally, the market includes research into the development of new immunosuppressive drugs to reduce the risk of organ rejection. The Kidney Transplant market is highly competitive, with many companies vying for a share of the market. Companies in the market include Astellas Pharma, Novartis, Roche, Merck, and Pfizer. Additionally, there are a number of smaller companies that specialize in the development of new treatments and technologies related to kidney transplantation. Show Less Read more